HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hayley L Letson Selected Research
Hayley L Letson Research Topics
Disease
12
Inflammation (Inflammations)
01/2022 - 08/2015
12
Hemorrhagic Shock
01/2022 - 06/2011
11
Hemorrhage
01/2022 - 08/2015
11
Wounds and Injuries (Trauma)
01/2022 - 09/2014
6
Shock
01/2022 - 08/2012
2
Burns
01/2021 - 01/2019
2
Tics (Tic)
03/2020 - 08/2015
2
Heart Failure
01/2020 - 01/2017
2
Multiple Organ Failure (MODS)
01/2020 - 01/2019
2
Sepsis (Septicemia)
01/2020 - 09/2014
2
Infections
09/2019 - 01/2019
2
Heart Arrest (Cardiac Arrest)
12/2014 - 09/2013
1
Anterior Cruciate Ligament Injuries
10/2022
1
Ischemia
01/2022
1
Margins of Excision
01/2022
1
Necrosis
01/2022
1
Fibrosis (Cirrhosis)
12/2021
1
Pica (Geophagia)
01/2021
1
Hyperthermia
01/2021
1
Cicatrix (Scar)
01/2021
1
Acute Lung Injury
01/2021
1
Weight Loss (Weight Reduction)
01/2021
1
Hypoxia (Hypoxemia)
01/2020
1
COVID-19
01/2020
1
Endotoxemia
01/2020
1
Compartment Syndromes
01/2019
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018
1
Brain Injuries (Brain Injury)
01/2018
1
Postpartum Hemorrhage
01/2018
1
Hypertension (High Blood Pressure)
01/2017
1
Postoperative Pain
01/2017
1
Respiratory Alkalosis
01/2017
1
Thrombocytopenia (Thrombopenia)
01/2017
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2017
1
Obesity
01/2017
1
Acidosis
05/2016
1
Thrombosis (Thrombus)
08/2015
1
Confusion (Bewilderment)
08/2015
1
Hypotension (Low Blood Pressure)
12/2014
1
Edema (Dropsy)
09/2014
Drug/Important Bio-Agent (IBA)
17
Adenosine (Adenocard)
FDA Link
Generic
01/2022 - 09/2011
16
Lidocaine (Xylocaine)
FDA Link
Generic
01/2022 - 09/2011
7
Magnesium
IBA
01/2022 - 09/2011
5
Fibrinogen (Factor I)
FDA Link
03/2020 - 05/2016
4
Tranexamic Acid (AMCA)
FDA Link
12/2021 - 01/2017
4
Lactic Acid (Lactate)
FDA Link
Generic
01/2020 - 05/2016
3
Buprenorphine (Subutex)
FDA Link
Generic
01/2022 - 01/2017
3
Solutions
IBA
12/2021 - 04/2019
3
adenocaine
IBA
09/2013 - 12/2011
2
Adrenergic Agents (Adrenergic Drugs)
IBA
01/2022 - 11/2021
2
Cytokines
IBA
01/2021 - 01/2018
2
Analgesics (Analgesic Drugs)
IBA
01/2021 - 01/2017
2
Thrombin
FDA Link
03/2020 - 08/2015
2
salicylhydroxamic acid (SHAM)
IBA
01/2019 - 04/2015
1
Cholinergic Receptors
IBA
01/2022
1
Cholinergic Agents (Cholinergics)
IBA
01/2022
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
11/2021
1
Sodium Chloride
FDA Link
Generic
01/2021
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2021
1
Matrix Metalloproteinases (MMPs)
IBA
01/2021
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
01/2021
1
carprofen
FDA Link
01/2021
1
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Thrombomodulin
IBA
03/2020
1
Annexins
IBA
03/2020
1
Glycerol (Glycerine)
FDA Link
Generic
01/2020
1
Pharmaceutical Preparations
IBA
01/2020
1
Oxygen (Dioxygen)
IBA
01/2020
1
Antigens
IBA
01/2020
1
Biocompatible Materials (Biomaterials)
IBA
09/2019
1
Vancomycin
FDA Link
Generic
01/2019
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2019
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018
1
Chemokine CCL5
IBA
01/2018
1
Protamines (Protamine Sulfate)
FDA Link
01/2017
1
Saline Solution
IBA
01/2017
1
antineoplaston A10 (A 10)
IBA
05/2016
1
Plasminogen Activator Inhibitor 1
IBA
05/2016
1
P-Selectin
IBA
05/2016
1
Fibrin
IBA
08/2015
1
Dacarbazine (DIC)
FDA Link
Generic
08/2015
Therapy/Procedure
10
Resuscitation
01/2021 - 09/2011
9
Therapeutics
01/2022 - 09/2014
6
Drug Therapy (Chemotherapy)
10/2022 - 09/2013
3
Fluid Therapy (Oral Rehydration Therapy)
01/2022 - 01/2020
3
Laparotomy
11/2021 - 01/2017
2
Analgesia
01/2022 - 01/2021
2
Knee Replacement Arthroplasty (Total Knee Replacement)
12/2021 - 09/2019
2
Intravenous Infusions
01/2018 - 01/2017
1
Catheters
01/2021
1
Continuity of Patient Care
01/2020
1
Defibrillators (Defibrillator)
01/2020
1
Reoperation
09/2019
1
Anesthesia
01/2019
1
Phage Therapy
01/2019
1
Orthopedic Procedures
06/2018
1
Sternotomy
01/2017
1
Ligation
09/2014
1
Punctures
09/2014